Three federal appeals judges—who have all ruled on 340B matters in the past—will hear oral arguments in September in a [...] …
Category: General
A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The dark money group behind a campaign targeting GOP-led states’ recent efforts to enact 340B contract pharmacy access laws released [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The debate over federal drug pricing reform could garner newfound attention on Capitol Hill now that Congress has wrapped up [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drugmakers announced new changes to their 340B contract pharmacy restrictions in notices posted to 340B ESP’s website late [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three drugmakers are offering refunds to 340B covered entities that purchased certain drugs between 2022 and 2025 following recalculations of [...] …